Literature DB >> 15738347

Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure.

Concetta Irace1, Claudio Cortese, Elio Fiaschi, Claudio Carallo, Giorgio Sesti, Eduardo Farinaro, Agostino Gnasso.   

Abstract

Elevated blood pressure is among the factors that contribute to the metabolic syndrome (MetS). It is not known whether subjects with MetS and elevated blood pressure are at the same cardiovascular risk as subjects with MetS but without elevated blood pressure. To clarify this point, we have evaluated the prevalence of carotid atherosclerosis in subjects with MetS with or without elevated blood pressure. A large population was examined (842 women and 1011 men). Blood pressure, lipids, glucose, and waist were measured by routine methods. Carotid atherosclerosis was evaluated by echo Doppler examination. The prevalence of MetS was 24.4% in women and 28.7% in men. The prevalence of carotid atherosclerosis was 35.1% in women and 37.3% in men (p=NS), and increased with increasing number of MetS components. Age, smoking, and systolic blood pressure (SBP) were associated with the presence of carotid atherosclerosis (logistic model), whereas age, high-density lipoprotein cholesterol, and SBP were associated with the extent of atherosclerosis (linear model). When comparing subjects with an equal number of MetS components, the prevalence of carotid atherosclerosis was significantly higher in subjects with elevated blood pressure than in those without. No difference in carotid atherosclerosis prevalence was found in subjects bearing or not bearing components of the syndrome other than elevated blood pressure. The present findings demonstrate that subjects with MetS and elevated blood pressure have increased carotid atherosclerosis compared with subjects with MetS but without elevated blood pressure. The diagnosis of MetS per se might not adequately identify subjects at elevated cardiovascular risk.

Entities:  

Mesh:

Year:  2005        PMID: 15738347     DOI: 10.1161/01.HYP.0000158945.52283.c2

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

Review 2.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

3.  Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study.

Authors:  Giovanni De Simone; Richard B Devereux; Marcello Chinali; Mary J Roman; Ana Barac; Julio A Panza; Elisa T Lee; Barbara V Howard
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

4.  Hypertension and decreased aortic compliance due to reduced elastin amounts do not increase atherosclerotic plaque accumulation in Ldlr-/- mice.

Authors:  Justine A Maedeker; Kellie V Stoka; Siddharth A Bhayani; William S Gardner; Lisa Bennett; Jesse D Procknow; Marius C Staiculescu; Tezin A Walji; Clarissa S Craft; Jessica E Wagenseil
Journal:  Atherosclerosis       Date:  2016-03-21       Impact factor: 5.162

5.  Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: a five-year follow-up study.

Authors:  Yu-Cheng Lin; Jong-Dar Chen; Su-Huey Lo; Pau-Chung Chen
Journal:  BMC Public Health       Date:  2010-12-02       Impact factor: 3.295

6.  Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects.

Authors:  Aldo Pende; Caterina Grondona; Stefano Bertolini
Journal:  Cardiovasc Ultrasound       Date:  2008-09-22       Impact factor: 2.062

7.  Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies.

Authors:  Amal F Alshammary; Khalid Khalaf Alharbi; Naif Jameel Alshehri; Vishal Vennu; Imran Ali Khan
Journal:  Int J Environ Res Public Health       Date:  2021-02-11       Impact factor: 3.390

8.  Systemic inflammation and lung function impairment in morbidly obese subjects with the metabolic syndrome.

Authors:  Astrid van Huisstede; Manuel Castro Cabezas; Erwin Birnie; Gert-Jan M van de Geijn; Arjan Rudolphus; Guido Mannaerts; Tjin L Njo; Pieter S Hiemstra; Gert-Jan Braunstahl
Journal:  J Obes       Date:  2013-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.